Bio-Techne is now ranked the #85 analyst pick among S&P 500 components, up 1 spot from the prior tally. The article is a factual update on relative analyst sentiment rather than a new operational or financial development. Market impact is likely minimal absent a change in estimates or company fundamentals.
Bio-Techne is now ranked the #85 analyst pick among S&P 500 components, up 1 spot from the prior tally. The article is a factual update on relative analyst sentiment rather than a new operational or financial development. Market impact is likely minimal absent a change in estimates or company fundamentals.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
